Methylprednisolone Tablets Recalled for Incorrect Blister Foil Orientation
Greenstone LLC is recalling methylprednisolone 4 mg tablets due to incorrect blister foil orientation that causes incorrect dosing directions on the packaging.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall involving incorrect dosing information on a corticosteroid medication, which presents a risk of harm through incorrect dosing. No illnesses or injuries have been reported, but the hazard is inherently serious given the drug's potency.
Plain-English summary
Greenstone LLC is recalling methylprednisolone tablets, USP Dosepak (4 mg, 21 tablets per blister card) because the blister foil has been incorrectly oriented. This orientation error causes the dosing directions printed on the foil to be incorrect.
The recall affects approximately 3456 cartons distributed nationwide in the United States. The affected lot is #LG7675 with an expiration date of November 2026. The product is distributed by Greenstone LLC, Peapack, NJ 07977, with NDC number 59762-4440-2.
Patients who are taking this medication should verify with their pharmacist or healthcare provider whether they have the recalled product. Do not stop taking this medication without first speaking with your healthcare provider. Anyone who suspects they may have taken an incorrect dose and experienced health concerns should consult their healthcare provider, who may report adverse events to the FDA.
The recalled product
- Product
- METHYLPREDNISOLONE (METHYLPREDNISOLONE)
- Brand
- METHYLPREDNISOLONE
- Manufacturer
- Greenstone Llc
- Category
- Drug
- Hazard
- mis-labeling
- incorrect-dosing
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # LG7675
- Exp. Date Nov 2026
UPCs (3)
- 0359762005014
- 0359762005113
- 0359762444035
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- LowBusulfan Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27